Sands Capital Life Sciences Pulse Fund III (DE), L.P. SEC EDGAR Filings (CIK 0001998695)

SEC EDGAR filings, ownership reports, and insider transactions for Sands Capital Life Sciences Pulse Fund III (DE), L.P..

Business address
C/O Sands Capital Ventures, Llc, 1000 Wilson Blvd., Suite 3000, Arlington, VA, 22209
Top holdings (Schedule 13G)
SpyGlass Pharma, Inc.
State of incorporation
DE
⭐ Add to watchlist ⭐
Sands Capital Life Sciences Pulse Fund III (DE), L.P. has filed 2 SEC EDGAR filings since 27 Oct 2023

Latest Filings

Recent SEC filings for Sands Capital Life Sciences Pulse Fund III (DE), L.P. including SCHEDULE 13G, D.

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 13 Feb 2026
D Open D document View SEC filing for D 27 Oct 2023 021-495781

About this filer

Sands Capital Life Sciences Pulse Fund III (DE), L.P. files with the SEC under CIK 0001998695. This page aggregates EDGAR filings and related ownership activity.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages